Cite
Thomson MC, Allen LA, Halpern SD, et al. Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM Policy Pract. 2021;6(2):23814683211041623doi: 10.1177/23814683211041623.
Thomson, M. C., Allen, L. A., Halpern, S. D., Ko, Y. A., Matlock, D. D., Mitchell, A. R., Moore, M. A., Morris, A. A., Rao, B. R., Scherer, L. D., Speight, C. D., Ubel, P. A., & Dickert, N. W. (2021). Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM policy & practice, 6(2), 23814683211041623. https://doi.org/10.1177/23814683211041623
Thomson, Mary C, et al. "Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure." MDM policy & practice vol. 6,2 (2021): 23814683211041623. doi: https://doi.org/10.1177/23814683211041623
Thomson MC, Allen LA, Halpern SD, Ko YA, Matlock DD, Mitchell AR, Moore MA, Morris AA, Rao BR, Scherer LD, Speight CD, Ubel PA, Dickert NW. Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM Policy Pract. 2021 Oct 18;6(2):23814683211041623. doi: 10.1177/23814683211041623. eCollection 2021. PMID: 34693019; PMCID: PMC8529322.
Copy
Download .nbib